We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling Dolby Laboratories (DLB) Q4 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
In its upcoming report, Dolby Laboratories (DLB - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.19 per share, reflecting an increase of 20.2% compared to the same period last year. Revenues are forecasted to be $368.37 million, representing a year-over-year increase of 20%.
The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
In light of this perspective, let's dive into the average estimates of certain Dolby Laboratories metrics that are commonly tracked and forecasted by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenue- Licensing' will likely reach $344.09 million. The estimate points to a change of +22.2% from the year-ago quarter.
Analysts expect 'Revenue- Products and services' to come in at $24.41 million. The estimate indicates a change of -3.9% from the prior-year quarter.
Based on the collective assessment of analysts, 'Revenue- Licensing- Market- PC' should arrive at $39.45 million. The estimate points to a change of +37.7% from the year-ago quarter.
Analysts predict that the 'Revenue- Licensing- Market- Other' will reach $66.70 million. The estimate points to a change of +10.9% from the year-ago quarter.
It is projected by analysts that the 'Revenue- Licensing- Market- CE' will reach $40.87 million. The estimate points to a change of +16.6% from the year-ago quarter.
Analysts forecast 'Revenue- Licensing- Market- Broadcast' to reach $126.60 million. The estimate suggests a change of +18.1% year over year.
The collective assessment of analysts points to an estimated 'Revenue- Licensing- Market- Mobile' of $72.41 million. The estimate indicates a year-over-year change of +43%.
The average prediction of analysts places 'Gross Margin- Licensing' at $320.30 million. The estimate is in contrast to the year-ago figure of $260.52 million.
The consensus among analysts is that 'Gross margin- Products and services' will reach $4.24 million. Compared to the current estimate, the company reported $6.99 million in the same quarter of the previous year.
Shares of Dolby Laboratories have experienced a change of +9.9% in the past month compared to the -2.4% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), DLB is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Unveiling Dolby Laboratories (DLB) Q4 Outlook: Wall Street Estimates for Key Metrics
In its upcoming report, Dolby Laboratories (DLB - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.19 per share, reflecting an increase of 20.2% compared to the same period last year. Revenues are forecasted to be $368.37 million, representing a year-over-year increase of 20%.
The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
In light of this perspective, let's dive into the average estimates of certain Dolby Laboratories metrics that are commonly tracked and forecasted by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenue- Licensing' will likely reach $344.09 million. The estimate points to a change of +22.2% from the year-ago quarter.
Analysts expect 'Revenue- Products and services' to come in at $24.41 million. The estimate indicates a change of -3.9% from the prior-year quarter.
Based on the collective assessment of analysts, 'Revenue- Licensing- Market- PC' should arrive at $39.45 million. The estimate points to a change of +37.7% from the year-ago quarter.
Analysts predict that the 'Revenue- Licensing- Market- Other' will reach $66.70 million. The estimate points to a change of +10.9% from the year-ago quarter.
It is projected by analysts that the 'Revenue- Licensing- Market- CE' will reach $40.87 million. The estimate points to a change of +16.6% from the year-ago quarter.
Analysts forecast 'Revenue- Licensing- Market- Broadcast' to reach $126.60 million. The estimate suggests a change of +18.1% year over year.
The collective assessment of analysts points to an estimated 'Revenue- Licensing- Market- Mobile' of $72.41 million. The estimate indicates a year-over-year change of +43%.
The average prediction of analysts places 'Gross Margin- Licensing' at $320.30 million. The estimate is in contrast to the year-ago figure of $260.52 million.
The consensus among analysts is that 'Gross margin- Products and services' will reach $4.24 million. Compared to the current estimate, the company reported $6.99 million in the same quarter of the previous year.
View all Key Company Metrics for Dolby Laboratories here>>>Shares of Dolby Laboratories have experienced a change of +9.9% in the past month compared to the -2.4% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), DLB is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .